These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 86625

  • 1. [Treatment with NK 631 (new bleomycin analog) of oral and maxillofacial cancer (author's transl)].
    Nakanishi K, Miki T, Adachi K, Teranobu O, Shimada K.
    Jpn J Antibiot; 1979 Feb; 32(2):282-90. PubMed ID: 86625
    [Abstract] [Full Text] [Related]

  • 2. [Clinical effects of NK 631 (pepleomycin) against malignant tumors of the head and neck (author's transl)].
    Satoh F, Saitoh H, Mizukoshi O.
    Jpn J Antibiot; 1979 Jul; 32(7):751-5. PubMed ID: 90743
    [Abstract] [Full Text] [Related]

  • 3. [Histological appearances of cancer of the head and neck treated with pepleomycin (NK 631) (author's transl)].
    Matsumura Y, Nomura Y, Eguchi S, Yanagita T.
    Jpn J Antibiot; 1978 Nov; 31(11):651-8. PubMed ID: 83401
    [Abstract] [Full Text] [Related]

  • 4. [Clinical application of NK 631 to head-and-neck cancers (author's transl)].
    Ogawa Y, Omata T, Imaizumi H, Shiga H, Ouchi J.
    Jpn J Antibiot; 1979 Jan; 32(1):115-20. PubMed ID: 84881
    [Abstract] [Full Text] [Related]

  • 5. [Clinical application of NK 631, a new derivative of bleomycin (author's transl)].
    Asahi M.
    Jpn J Antibiot; 1979 Jul; 32(7):744-50. PubMed ID: 90742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical effects of NK 631 in malignant tumors of the oral cavity (author's transl)].
    Kawahira K, Dohhara Y, Sugihara K, Yamada K, Fujinami Y, Saku T, Yamashita S.
    Jpn J Antibiot; 1979 Jan; 32(1):138-48. PubMed ID: 84884
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Controlled studies with bleomycin in solid tumors and lymphomas.
    Bonadonna G, Tancini G, Bajetta E.
    Prog Biochem Pharmacol; 1976 Jan; 11():172-84. PubMed ID: 63961
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experience with pepleomycin (NK 631) (author's transl)].
    Hashimoto K, Shioda S, Amagasa T, Shimizu M, Sato O, Ito H, Fujibayashi T, Soda T.
    Jpn J Antibiot; 1979 Mar; 32(3):451-62. PubMed ID: 86627
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current status of American studies with bleomycin.
    Carter SK, Blum RH.
    Prog Biochem Pharmacol; 1976 Mar; 11():158-71. PubMed ID: 63960
    [No Abstract] [Full Text] [Related]

  • 17. [Preoperative application of NK 631 for carcinoma of oral cavity (author's transl)].
    Yamamoto E, Sunakawa H, Kohama GI.
    Jpn J Antibiot; 1979 Feb; 32(2):253-8. PubMed ID: 86621
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Application of BLM-iontophoresis for the tumor-therapy of the head and neck area (author's transl)].
    Hayasaki K, Kitamura T, Kaneko T, Tachibana M, Kobayashi N, Tosaka K, Yaku Y.
    Nihon Gan Chiryo Gakkai Shi; 1977 Dec 20; 12(4):522-7. PubMed ID: 75935
    [No Abstract] [Full Text] [Related]

  • 20. [Studies on the clinical effect of NK 631 for oral-cavity cancers (author's transl)].
    Ohashi Y, Abe M, Saito K, Mizutani H, Onishi S, Ueda N.
    Jpn J Antibiot; 1979 Feb 20; 32(2):259-64. PubMed ID: 86622
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.